search
Back to results

The Usefulness of Biatrial 3D Printing to Plan Transseptal Puncture for the Left Atrial Appendage Closure

Primary Purpose

Atrial Fibrillation, Left Atrial Appendage Closure

Status
Recruiting
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
Left atrial appendage closure
Sponsored by
Charles University, Czech Republic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Atrial Fibrillation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: atrial fibrillation (paroxysmal or non-paroxysmal) CHA2DS2VASc more or equal 2 (Congestive heart failure, Hypertension, Age > 75 years, Diabetes, Stroke, Vascular disease, Age > 65 years, female sex) Contraindications for long-term anticoagulation Exclusion Criteria: allergy to contrast dye non-willingness to participate left atrial appendage thrombus

Sites / Locations

  • Cardiocenter, 3rd Medical School, Charles University and University Hospital Kralovske VinohradyRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

3D printing arm

Arm Description

A bi-atrial 3D printed model will be manufactured before the procedure

Outcomes

Primary Outcome Measures

Procedure satisfaction, scale 1-3 (1- optimum, 2-possible to implant, 3-impossible to implant)
The satisfaction with the transseptal puncture for the purpose of the procedure, assessed by the operator
Angle between the delivery sheath and the LAA axis
the axis between the delivery sheath with the axis of the left atrial appendage will be analysed in two orthogonal projections
Number of recaptures of the device
Number of recaptures of the device

Secondary Outcome Measures

Procedural complications
Tamponade, device embolization, stroke

Full Information

First Posted
February 1, 2023
Last Updated
February 21, 2023
Sponsor
Charles University, Czech Republic
Collaborators
Brno University Hospital, General Teaching Hospital, Prague
search

1. Study Identification

Unique Protocol Identification Number
NCT05743322
Brief Title
The Usefulness of Biatrial 3D Printing to Plan Transseptal Puncture for the Left Atrial Appendage Closure
Official Title
The Usefulness of Pre-procedural 3D Print of Both Atria to Plan Transseptal Puncture for the Left Atrial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 1, 2021 (Actual)
Primary Completion Date
August 1, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Charles University, Czech Republic
Collaborators
Brno University Hospital, General Teaching Hospital, Prague

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of the study is to assess the usefulness of pre-procedural 3D printing of both atria to plan optimum site for transseptal puncture for the left atrial appendage closure.
Detailed Description
All patients referred for the left atrial appendage closure will be enrolled. Before the procedure, cardiac CT (computed tomography) will be done. Using cardiac CT, segmentation procedure will be performed. The segmented 3D biatrial reconstruction will be exported in the stereolithography (STL) format and then printed out. Before every procedure as a part of pre-procedural planning, TSP puncture will be simulated in vitro using the three-dimensional printing (3DP) models and a 12 Fr delivery sheath. Six holes (TSP locations) through the intraatrial septum will be performed from the right side of the septum by a cordless drill. The puncture sites will be localised as follows: three in the cranial part of the fossa ovalis (FO) (anteriorly just behind the aortic root, in the middle and posteriorly) and three in the caudal portion of the FO in the identical way. The delivery sheath will be inserted through each preformed hole and its distal tip was positioned in the LAA (10 - 20 mm deep). The relationship of the sheath and the proximal LAA segment will be evaluated in two orthogonal views. Two criteria had to be met in both views to classify the puncture site as optimal: (1) a central sheath position and (2) a coaxial sheath position (the angle with the LAA ostium axis not exceeding 30°). All procedures will be done by experienced operators according to the actual guidelines. Intracardiac echocardiography (ICE) or transesophageal echocardiography (TEE) will be used. Before the procedure, each operator received a recommendation regarding the optimal puncture sites. In ICE guided cases, based on the LA anatomical structures visible in the projection plane during TSP, the puncture site was classified as posterior (left-sided pulmonary veins visible), middle (coumadin ridge visible), or anterior (LAA and mitral annulus visible). In TEE guided procedures mainly mid-oesophageal aortic valve short axis view (∼ 25-45°) and mid-oesophageal bicaval view (∼ 90-110°) will be used. Depending on in which third of the interatrial septum the puncture was performed, it will be classified as anterior, middle, or posterior (aortic valve short axis view). The bicaval projection showed the cranio-caudal localization. The 3DP models were not used for device sizing, it was done based on the CT data and intra-procedural angiography according to the performing physicians' preferences. The procedural difficulty will be assessed by the operator (focused on the alignment of the delivery assembly with the LAA axis). Furthermore, the number of recaptures of devices will be analyzed, as well as the number of unsuccessful procedures and procedural complications. Additional golas of the project are: to analyse the distribution of optimal puncture sites and to correlate CT 2D measurements with those findings.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation, Left Atrial Appendage Closure

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
3D printing arm
Arm Type
Experimental
Arm Description
A bi-atrial 3D printed model will be manufactured before the procedure
Intervention Type
Device
Intervention Name(s)
Left atrial appendage closure
Intervention Description
Left atrial appendage will be occluded using commercially available device
Primary Outcome Measure Information:
Title
Procedure satisfaction, scale 1-3 (1- optimum, 2-possible to implant, 3-impossible to implant)
Description
The satisfaction with the transseptal puncture for the purpose of the procedure, assessed by the operator
Time Frame
It will be assessed immediately after the procedure, i.e. on the day of the procedure
Title
Angle between the delivery sheath and the LAA axis
Description
the axis between the delivery sheath with the axis of the left atrial appendage will be analysed in two orthogonal projections
Time Frame
It will be assessed immediately after the procedure, i.e. on the day of the procedure
Title
Number of recaptures of the device
Description
Number of recaptures of the device
Time Frame
It will be assessed immediately after the procedure, i.e. on the day of the procedure
Secondary Outcome Measure Information:
Title
Procedural complications
Description
Tamponade, device embolization, stroke
Time Frame
Until 30 days after the procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: atrial fibrillation (paroxysmal or non-paroxysmal) CHA2DS2VASc more or equal 2 (Congestive heart failure, Hypertension, Age > 75 years, Diabetes, Stroke, Vascular disease, Age > 65 years, female sex) Contraindications for long-term anticoagulation Exclusion Criteria: allergy to contrast dye non-willingness to participate left atrial appendage thrombus
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marek Hozman
Phone
+420728135358
Email
hozmanm@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pavel Osmancik
Organizational Affiliation
Cardiac center University Hospital Kralovske Vinohrady
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cardiocenter, 3rd Medical School, Charles University and University Hospital Kralovske Vinohrady
City
Prague
ZIP/Postal Code
10034
Country
Czechia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pavel Osmancik, MD, PhD
Phone
00420
Ext
721544447
Email
pavel.osmancik@volny.cz

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data will be shared and available after the publication
IPD Sharing Time Frame
After 6 months after the publication, on request
IPD Sharing Access Criteria
On request

Learn more about this trial

The Usefulness of Biatrial 3D Printing to Plan Transseptal Puncture for the Left Atrial Appendage Closure

We'll reach out to this number within 24 hrs